Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Burnell

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
British Journal of Cancer|August 19, 2015
TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trialJ M S Bartlett, T O Nielsen, D Gao, et al.
Environmental Microbiology|September 5, 2015
An analysis of Pseudomonas genomic diversity in take-all infected wheat fields reveals the lasting impact of wheat cultivars on the soil microbiotaT H Mauchline, D Chedom-Fotso, G Chandra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trialsR Yerushalmi, B Dong, J W Chapman, et al.
Breast Cancer Research and Treatment|January 2, 2015
Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trialShuzhen Liu, Judy-Anne W Chapman, Margot J Burnell, et al.
Breast Cancer Research and Treatment|April 3, 2015
Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancerAna Elisa Lohmann, Judy-Anne W Chapman, Margot J Burnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II TrialNick Pavlakis, Katrin M Sjoquist, Andrew J Martin, et al.
NPJ Breast Cancer|June 9, 2021
Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trialPamela J Goodwin, Ryan J O Dowling, Marguerite Ennis, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2010
Divergent and nonuniform gene expression patterns in mouse brainJohn A Morris, Joshua J Royall, Darren Bertagnolli, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
British Journal of Cancer|August 19, 2015
TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trialJ M S Bartlett, T O Nielsen, D Gao, et al.
Environmental Microbiology|September 5, 2015
An analysis of Pseudomonas genomic diversity in take-all infected wheat fields reveals the lasting impact of wheat cultivars on the soil microbiotaT H Mauchline, D Chedom-Fotso, G Chandra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trialsR Yerushalmi, B Dong, J W Chapman, et al.
Breast Cancer Research and Treatment|January 2, 2015
Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trialShuzhen Liu, Judy-Anne W Chapman, Margot J Burnell, et al.
Breast Cancer Research and Treatment|April 3, 2015
Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancerAna Elisa Lohmann, Judy-Anne W Chapman, Margot J Burnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II TrialNick Pavlakis, Katrin M Sjoquist, Andrew J Martin, et al.
NPJ Breast Cancer|June 9, 2021
Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trialPamela J Goodwin, Ryan J O Dowling, Marguerite Ennis, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2010
Divergent and nonuniform gene expression patterns in mouse brainJohn A Morris, Joshua J Royall, Darren Bertagnolli, et al.
Pageof 3